New figures reveal a devastating shortfall in the rollout of the long-acting HIV prevention drug lenacapavir, with experts warning current plans are insufficient to change the course of the pandemic.
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
The NHS will pay 25% more for new medicines under a UK-US trade agreement, costing taxpayers £3bn. The deal secures zero tariffs for UK pharmaceutical exports to America. Discover the full impact.
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
Exclusive report reveals how Donald Trump repeatedly dismissed crucial scientific evidence from the National Academy of Sciences during his presidency, undermining expert advice on critical policy matters.
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Exclusive analysis of the Guardian's 2025 league table reveals which UK universities are leading in biological sciences. Discover the top performers and rising stars shaping the next generation of biologists.
Exclusive guide to the best UK universities for Earth and Marine Sciences. Discover which institutions lead in climate research, oceanography, and environmental science for 2025.
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
The gripping account of the 'Aberdeen Three' animal rights activists whose 1987 lab raid led to unprecedented terrorism charges, a landmark trial, and a seismic shift in UK activism.
The European Medicines Agency has approved a groundbreaking HIV prevention drug, marking a significant step forward in public health. Learn more about this medical milestone.